আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
mitomycin medac duft og leysir fyrir þvagblöðrulausn 40 mg
medac gesellschaft für klinische spezialpräparate gmbh - mitomycinum inn - duft og leysir fyrir þvagblöðrulausn - 40 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
carepen vet spenalyf, dreifa 600 mg
vetcare ltd.* - benzylpenicillinprocainum - spenalyf, dreifa - 600 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
vinorelbin actavis innrennslisþykkni, lausn 10 mg/ml
actavis group ptc ehf. - vinorelbinum tvítartrat - innrennslisþykkni, lausn - 10 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
gentamicin b. braun innrennslislyf, lausn 1 mg/ml
b. braun melsungen ag - gentamicinum súlfat - innrennslislyf, lausn - 1 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
gentamicin b. braun innrennslislyf, lausn 3 mg/ml
b. braun melsungen ag - gentamicinum súlfat - innrennslislyf, lausn - 3 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
bleomycin baxter stungulyfs-/innrennslisstofn, lausn 15.000 a.e.
baxter medical ab* - bleomycinum súlfat - stungulyfs-/innrennslisstofn, lausn - 15.000 a.e.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
carboplatin actavis innrennslisþykkni, lausn 10 mg/ml
actavis group ptc ehf. - carboplatinum inn - innrennslisþykkni, lausn - 10 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
doxorubicin medac innrennslislyf, lausn 2 mg/ml
medac gesellschaft für klinische spezialpräparate gmbh - doxorubicinum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
gentacoll vefjalyf 1,3 mg/cm2
serb s.a. - gentamicinum súlfat - vefjalyf - 1,3 mg/cm2
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
efient
substipharm - prasugrel - acute coronary syndrome; angina, unstable; myocardial infarction - blóðþurrðandi lyf - efient, gefið samhliða acetýlsalicýlsýru (asa), er ætlað til að koma í veg fyrir segamyndun í aterrótrótein hjá sjúklingum með bráða kransæðasjúkdóm (ég. óstöðug hjartslætti, non-l-hluti-hæð kransæðastíflu [ha / nstemi] eða l-hluti-hæð kransæðastíflu [st-hækkun]) gangast undir aðal eða frestað um kransæðastíflu afskipti (náist á ný).